Live-Cell Synchrotron-Based FTIR Evaluation of Metabolic Compounds in Brain Glioblastoma Cell Lines after Riluzole Treatment
- 29 December 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (4) , 1932-1940
Abstract
Glioblastoma multiforme (GBM) is the most aggressive brain tumor, characterized by short median survival and an almost 100% tumor-related mortality. The standard of care treatment for newly diagnosed GBM includes surgical resection followed by concomitant radiochemotherapy. The prevention of disease progression fails due to the poor therapeutic effect caused by the great molecular heterogeneity of this tumor. Previously, we exploited synchrotron radiation-based soft X-ray tomography and hard X-ray fluorescence for elemental microimaging of the shock-frozen GBM cells. The present study focuses instead on the biochemical profiling of live GBM cells and provides new insight into tumor heterogenicity. We studied bio-macromolecular changes by exploring the live-cell synchrotron-based Fourier transform infrared (SR-FTIR) microspectroscopy in a set of three GBM cell lines, including the patient-derived glioblastoma cell line, before and after riluzole treatment, a medicament with potential anticancer properties. SR-FTIR microspectroscopy shows that GBM live cells of different origins recruit different organic compounds. The riluzole treatment of all GBM cell lines mainly affected carbohydrate metabolism and the DNA structure. Lipid structures and protein secondary conformation are affected as well by the riluzole treatment: cellular proteins assumed cross β-sheet conformation while parallel β-sheet conformation was less represented for all GBM cells. Moreover, we hope that a new live-cell approach for GBM simultaneous treatment and examination can be devised to target cancer cells more specifically, i.e., future therapies can develop more specific treatments according to the specific bio-macromolecular signature of each tumor type.Keywords
Funding Information
- Ministerio de Ciencia, Innovaci??n y Universidades (RYC2018-024043-I)
- Alba Synchrotron (2020014052)
This publication has 61 references indexed in Scilit:
- Synergistic Inhibition of Survival, Proliferation, and Migration of U87 Cells with a Combination of LY341495 and IressaPLOS ONE, 2013
- Transforming Fusions of FGFR and TACC Genes in Human GlioblastomaScience, 2012
- Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagyFree Radical Biology and Medicine, 2012
- SNAI1 is Involved in the Proliferation and Migration of Glioblastoma CellsCellular and Molecular Neurobiology, 2011
- Fabrication of a microfluidic platform for investigating dynamic biochemical processes in living samples by FTIR microspectroscopyMicroelectronic Engineering, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Chronic Riluzole Treatment Increases Glucose Metabolism in Rat Prefrontal Cortex and HippocampusJournal of Cerebral Blood Flow & Metabolism, 2008
- Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channelsBritish Journal of Pharmacology, 2003